Skip to main content
News_Bradke
© Barbara Frommann / DZNE

News categories: Honors & Funding

Frank Bradke receives Remedios Caro Almela Prize

Neurobiologist and ImmunoSensation² member Frank Bradke, a senior researcher at the German Center for Neurodegenerative Diseases (DZNE) and a professor at the University of Bonn, will be awarded with the „Remedios Caro Almela Prize for Research in Developmental Neurobiology“, which is endowed with 25,000 Euros. He is being honored for his groundbreaking research on the growth and regeneration of neurons. The award ceremony will take place in Alicante, Spain in November.

Since 2011, Frank Bradke and his team have been investigating at DZNE how nerve cells grow in their early developmental phases and whether it is possible to reactivate the growth of cells of the central nervous system even in the adult. They have achieved groundbreaking findings in particular about the growth of axons, those long extensions of nerve cells that do not regenerate on their own after lesion and thus play a decisive role in spinal cord injuries and the associated paraplegia. With their work, they are laying the foundations for possible pharmacological therapies for these injuries.

"I am really excited about this award. Many of my ‘scientific heroes’ received this prize in the past", Bradke said. "And I feel humbled by the jury that selected me to be part of this group. The prize is an outstanding recognition of the research of our lab. Over the years, lab members, including Postdocs, PhD students and technicians, contributed with very diverse backgrounds and their individual work and perspective to our joint research effort. Their success is reflected in this prize."

For Prof. Pierlugi Nicotera, Scientific Director and Chairman of the Board of the DZNE, the award is a well-deserved recognition of the excellent research conducted at DZNE by Frank Bradke and his research group: "Frank Bradke is one of the world's key experts in regenerative neurobiology, and we are delighted that he is receiving the international recognition he deserves for the pioneering research he has been conducting for many years. The award is further confirmation of him being on the right track."

The objective of the Remedios Caro Almela Prize for Research in Developmental Neurobiology is to recognize the work of European researchers who have carried out particularly outstanding scientific work in this field and who are currently carrying out cutting-edge research in the development of the nervous system. The biennial award is organized by the Institute for Neuroscience UMH-CSIC and the University Miguel Hernandez de Elche in collaboration with the Martinez-Caro family.

During the award ceremony, which will take place on November 24th, Frank Bradke will give a lecture at the XI. Caro Almela Conference at the Institute for Neurosciences UMH-CSI, in order to present his scientific achievements.

short biography

After studying at the Freie Universität Berlin and University College London, Bradke carried out research at the European Molecular Biology Laboratory (EMBL) in Heidelberg as part of his doctoral thesis. As a postdoctoral researcher, he moved to the University of California in San Francisco and Stanford University in 2000. In 2003, he was appointed a group leader at the Max Planck Institute of Neurobiology in Martinsried. In 2011, he was awarded the IRP Schellenberg Prize, one of the most prestigious awards in the field of regeneration research. In the same year he became full professor at the University of Bonn, and was appointed head of the Axon Growth and Regeneration research group at the DZNE. Bradke is an elected a member of the Leopoldina (the German National Academy of Sciences), the Academia Europaea, and the European Molecular Biology Organization (EMBO). In 2016, he was awarded the Leibniz Prize, which is the most important research award in Germany. In 2018, he received the Roger de Spoelberch Prize, which is awarded by the Swiss foundation of the same name. In 2021, he was awarded the Carl Zeiss Lecture of the German Society for Cell Biology.

(source: https://www.dzne.de/en/news/press-releases/press/dzne-scientist-receives-remedios-caro-almela-prize/)

Related news

Sandra Zeidler and Dr. Christine Wuebben (from left to right) from Bonn at the Pitch4Med Contest at the Heinrich Heine University Düsseldorf

News categories: Honors & Funding

ImmunoSensation entrepreneurs successfully pitch an innovative approach to fight respiratory viruses with an immunostimulatory nasal spray

A team of researchers in the group of Gunther Hartmann at the Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, and the Cluster of Excellence ImmunoSensation2 successfully pitched their start-up idea of Coldex, a nasal spray that provides protection from viral infections, at the Pitch4Med Contest at the Heinrich Heine University Düsseldorf and the 2nd Medical Pitch Contest of the Medical Faculty, University of Bonn.
View entry
Picture Florian Schmidt and Jan Hasenauer

News categories: Honors & Funding

Two ERC Consolidator Grants for ImmunoSensation members

Another big success for the University of Bonn in securing grants from the European Research Council (ERC), with three researchers receiving an ERC Consolidator Grant. Two of those grants go to ImmunoSensation2 researchers: Professor Jan Hasenauer of the LIMES Institute and Professor Florian I. Schmidt of the Institute for Innate Immunity.
View entry
Symbolic photo - Large amounts of data were analyzed for the "Highly Cited Researchers".

News categories: Honors & Funding

5 Highly Cited Researchers at ImmunoSensation

With a total of 11 researchers, the University of Bonn is represented this year in the international ranking "Highly Cited Researchers". ImmunoSensation is represented with 5 "Highly Cited Researchers" in Immunology and Cross-Field.
View entry

Back to the news overview